Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colestyramine crossover trial in hemodialysis patients with chronic renal insufficiency
2017-001899-32Phase 3Terminated
- Sponsor
- Dr. Abelardo Aguilera Peralta
- Start
- Aug 2017
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cholestyramine in chronic kidney disease (CKD) (2 arms), sponsored by Dr. Abelardo Aguilera Peralta. Started Aug 2017; status: terminated.
02
Drugs
cholestyramine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2017-001899-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001899-32.